Bafna Pharmaceuticals Share Price
Know More₹82.50 0.00 (0.00%)
04:01 PM, 15-Jan-2025₹84.00 3.48 (4.32%)
03:31 PM, 20-Jan-2025BSE : 532989
NSE : BAFNAPH
Sector : Health care
ISIN Code : INE878I01022
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 15-Jan-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 195 |
Traded Value (₹ Cr) | 0.01 |
Volume (Shares) | 1,002 |
Face Value (₹) | 10 |
52-Week High (₹) | 112.20 |
52-Week High Date | 07-May-2024 |
52-Week Low (₹) | 73.35 |
52-Week Low Date | 24-Jun-2024 |
All Time High (₹) | 195.95 |
All Time High Date | 23-Mar-2021 |
All Time Low (₹) | 4.65 |
All Time Low Date | 23-Aug-2019 |
Bafna Pharmaceuticals Ltd
Market News
Bafna Pharma. Announcement
Bafna Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 199 |
| EPS - TTM (₹) [C] | 0.00 |
| P/E Ratio (X) [C] | - |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 6.00 |
| Latest Dividend Date | 19-Sep-2013 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 21.61 |
| P/B Ratio (₹) [C] | 3.89 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 80.03 84.54 |
| Week Low/High (₹) | 78.50 85.00 |
| Month Low/High (₹) | 78.00 87.00 |
| Year Low/High (₹) | 73.25 113.00 |
| All time Low/High (₹) | 4.65 234.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -0.39% | 1.40% | 0.97 | 1.12% |
| 1 Month | 3.70% | 3.14% | -1.24 | -1.03% |
| 3 Month | 7.54% | 4.26% | -5.11 | -6.07% |
| 6 Month | -3.33% | -1.18% | -4.38 | -4.84% |
| 1 Year | -16.09% | -17.49% | 7.91 | 8.22% |
| 3 Year | -40.21% | -41.14% | 29.61 | 31.47% |
Company Info
Company Information
Non-Exec. & Independent Dir. : Babulal Kamlesh Kumar
Chairperson / Executive Director : Shanmugam Hemalatha
Non-Exec & Non-Independent Dir : Akilapriya Chandrashekar Raju
Non-Exec. & Independent Dir. : Palamadai Krishnan Sundaresan
Non-Exec. & Independent Dir. : Ravichandran Chitra
Non Executive Director : Upendar Mekala Reddy
Independent Director : Krishna Yeachuri
Whole-time Director : Vinayak Dinesh Dendukuri
Company Sec. & Compli. Officer : A Mohanachandran
Registered Office: Bafna Towers New No 68, Old No 299 Thambu Chetty St,Chennai,Tamil Nadu-600001 Ph: 91-44-25267517/25270992/4267755
FAQs about Bafna Pharmaceuticals Ltd
1. What's the Bafna Pharmaceuticals Ltd share price today?
Bafna Pharmaceuticals Ltd share price was Rs 82.50 at 04:01 PM IST on 15th Jan 2025. Bafna Pharmaceuticals Ltd share price was up by 0.00% over the previous closing price of Rs 82.50. Bafna Pharmaceuticals Ltd share price trend:
- Last 1 Month: Bafna Pharmaceuticals Ltd share price moved up by 3.70% on BSE
- Last 3 Months: Bafna Pharmaceuticals Ltd share price moved up by 7.54% on BSE
- Last 12 Months: Bafna Pharmaceuticals Ltd share price moved down by 16.09% on BSE
- Last 3 Years: Bafna Pharmaceuticals Ltd price moved down by 40.21% on BSE
2. How can I quickly analyse the performance of the Bafna Pharmaceuticals Ltd stock?
The performance of the Bafna Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is _
- Price to book value ratio is 3.89
- Dividend yield of 0.00
- The EPS (trailing 12 months) of the Bafna Pharmaceuticals Ltd stock is Rs 0.00
3. What is the market cap of Bafna Pharmaceuticals Ltd?
Bafna Pharmaceuticals Ltd has a market capitalisation of Rs 195 crore.
4. What is Bafna Pharmaceuticals Ltd's 52-week high/low share price?
The Bafna Pharmaceuticals Ltd’s 52-week high share price is Rs 112.20 and 52-week low share price is Rs 73.35.
5. Is the Bafna Pharmaceuticals Ltd profitable?
On a consolidated basis, Bafna Pharmaceuticals Ltd reported a profit of Rs 2.62 crore on a total income of Rs 41.34 crore for the quarter ended 2024. For the year ended Sep 2024, Bafna Pharmaceuticals Ltd had posted a profit of Rs 2.62 crore on a total income of Rs 41.35 crore.
6. Which are Bafna Pharmaceuticals Ltd’s peers in the Health care sector?
Bafna Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Krebs Biochem, Kimia Bioscien., Syschem (India), BDH Industries, Murae Organisor, Bal Pharma, Parnax Lab.
7. Who owns how much in Bafna Pharmaceuticals Ltd?
Key changes to the Bafna Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Bafna Pharmaceuticals Ltd has gone up to 88.30 per cent as of Dec 2024 from 88.30 per cent as of Mar 2024.
